Image

DRIVing Simulator and People With NeuroCognitive Disorders

DRIVing Simulator and People With NeuroCognitive Disorders

Recruiting
50-95 years
All
Phase N/A

Powered by AI

Overview

The ageing of the population is leading to an increasing number of older drivers on the roads. At the same time, the proportion of older people with pathological ageing and neurocognitive disorders (NCD) is increasing. In terms of road safety, this raises the question of whether these drivers should continue to drive or not. People with NCDs may not be aware of the presence, extent and progression of their cognitive impairment and the impact it can have on daily life, including driving.

Despite their loss of autonomy and medical advice, 22% of people with major NCD continue to drive. In addition, the presence of minor NCD also puts people at a higher risk of road accidents.

However, several studies demonstrated that an NCD does not lead to a systematic and immediate impairment of driving ability and abruptly stopping driving leads to health problems, such as the risk of depression and greatly reduces quality of life.

It is therefore relevant to focus research on driving with people with NCD in order to have a reliable indicator of the person's abilities and the impact of their cognitive impairment on driving activity. The proposed study seeks to meet this need by studying the performance of people with NCD on a driving station (mini-simulator) while assessing their ability to evaluate their performance.

To achieve this goal, people with NCDs will perform tasks on a driving simulator. In addition, after each task on the driving simulator, they will answer questions about how they evaluate their own driving. Two assessors will observe the participants' driving and will estimate their driving performance. By comparing the driver's self-assessment with the assessors' assessment, an "awareness score of driving ability" will be calculated to determine whether the driver correctly assessed his or her performance.

Another project already underway aims to collect similar data from people without a diagnosis of NCDs (control group).

The principal objective of the present study is to compare the driving performance in a simulator and the awareness of driving ability of people with NCDs with those of a control group. Secondary objectives are :

  1. to measure driving performance in a simulator and awareness of driving abilities (i.e. self-assessment skills) of people with NCDs.
  2. to analyse driving performance and awareness of driving abilities according to the diagnosis and severity of the disorder (i.e. minor or major neurocognitive disorders).
  3. to establish a methodology to identify a driver at risk of dangerous driving.

It is mainly an exploratory study however some hypotheses can be made :

  • The driving performance and awareness of driving skills of people with NCDs are poorer compared to those of older, control individuals.
  • Individuals' driving performance and awareness of driving ability are lower in the presence of major NCDs compared to minor NCDs.

Eligibility

Inclusion Criteria:

  • Diagnosed with Neurocognitive Disorders according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V)
  • Normal or corrected vision
  • B licence holder with 3+ years driving experience
  • Active drivers or drivers who stopped driving less than 2 months ago (time between the medical consultation and the day in the day care hospital)
  • For participants able to give consent:
    • Written informed consent to participate in the study
    • Informed consent of the participant in the presence of his/her curator.
  • For participants who are not able to receive information and to give consent:
    • Written informed consent of the legal representative (tutor) for participants under tutelage.
    • Signature of a relative (family member and/or trusted person) of the participant
  • The participant has to be affiliated to a social security scheme.

Exclusion Criteria:

  • History of epilepsy
  • People with vestibular disorders, motion sickness or migraines
  • Psychiatric history (e.g. schizophrenia)
  • Non-stabilized use of antidepressants and/or anxiolytics (started or modified within the last 3 months)
  • History of alcoholism
  • Use of anti-epileptics
  • Osteo-articular pathologies compromising walking

Study details
    Neurocognitive Disorders

NCT06320639

University Gustave Eiffel

3 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.